BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Medilink Midlands - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Medilink Midlands
X-ORIGINAL-URL:https://staging.medilinkmidlands.com
X-WR-CALDESC:Events for Medilink Midlands
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20251113T110000
DTEND;TZID=Europe/London:20251113T150000
DTSTAMP:20260407T163742
CREATED:20250416T154802Z
LAST-MODIFIED:20251016T130829Z
UID:36059-1763031600-1763046000@staging.medilinkmidlands.com
SUMMARY:IN-PERSON EVENT: Medilink Midlands Winter Networking
DESCRIPTION:Join Medilink Midlands for a touch of luxury as we host this year’s Winter Networking event in the beautiful grounds of Chatsworth Estate.\nEnjoy a delicious 2-course Business Lunch\, networking and first-hand updates around Medilink Midlands and the sector before heading into the festive Christmas market where you can find some of the finest products to help you get ahead of the Christmas rush. \nAgenda:  \n11am          Arrival & Networking \n11:30am    Welcome from Medilink Midlands and Member Forum \n11:50am    An interview with Dr Ewa Truchanowicz FRSA and Olivia Simpson\, Symbiotex. \nEwa will be questioning Olivia and delving into her passion for innovation and unwavering commitment to environmental and social responsibility. \n12:20pm   Member Spotlight \n12:30pm   Guest speaker: Adamson Jones \n12:40pm    2-course Business Lunch & Networking \n\nMenu\nMain Course \nGlazed Chatsworth ham served with roast potatoes\, stuffing\, seasonal vegetables and gravy \nOR \nSeasonal Nut Roast\, roast potatoes\, stuffing\, root vegetables\, and a vegan gravy (Ve) \n\nDessert \nChocolate orange tart (Ve/GF)  \n*Please ensure you disclose any specific dietary requirements when booking\, eg. Allergies.\n  \n1:45pm      Closing Comments \n2pm           Access to the Chatsworth Christmas Market and depart at leisure \n  \nThank you to event sponsor: Adamson Jones \n \nWhat your ticket includes:\n \n\nCar Parking and shuttle bus to event space\nTea or coffee on arrival\nTwo-Course festive-themed business lunch\nDrink to accompany lunch (wine or non-alcoholic cocktail available)\nExclusive update from Medilink Midlands during the Member Forum section\nAccess to Chatsworth Christmas Market\n\nTickets: \nMember ticket: £35 +VAT \nNon-member tickets: £50 +VAT \n  \n\nNB. Please email events@medilinkmidlands.com for booking codes. \n*Please note\, registration for this event closes at 5pm on Friday 31st October and spaces are limited\, book early to avoid disappointment. \n  \nSpeakers\n \nDr Ewa Truchanowicz FRSA \nEwa is a business leader and independent advisor experienced in building successful enterprises and providing consulting services to technology-focused organisations ranging from start-ups to multinationals. Until recently\, a Managing Director of a health tech company\, she is an expert in supporting international companies within digital and med-tech\, building highly performing teams and operations\, and creating strategic support networks to help innovative companies succeed. Ewa is an educator on tech and health\, a speaker at national and international events\, a mentor\, a health-tech executive\, and a NED with experience from Boards governing publicly funded and commercial organisations. She is also a successful published academic and has authored peer-reviewed publications within the highest-ranking medical journals\, including BMJ and NEJM. A former bid reviewer for NIHR\, an assessor for Innovate UK\, an honorary lecturer in a medical school and a visiting industrial fellow at UK Universities. \n 
URL:https://staging.medilinkmidlands.com/event/in-person-event-medilink-midlands-winter-networking-2025/
LOCATION:Chatsworth Estate\, Chatsworth House\, Bakewell\, Derbyshire\, DE45 1PP\, United Kingdom
CATEGORIES:Medilink Midlands Event
ORGANIZER;CN="Linsey Horsepool Medilink Midlands":MAILTO:events@medilinkmidlands.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20251121T093000
DTEND;TZID=Europe/London:20251121T163000
DTSTAMP:20260407T163742
CREATED:20250815T093108Z
LAST-MODIFIED:20251117T102932Z
UID:37777-1763717400-1763742600@staging.medilinkmidlands.com
SUMMARY:IN PERSON Event: Innovations Against AMR 2025
DESCRIPTION:    \n                         \n\n\nThe 4th annual Innovations Against AMR summit\, co-organised by Medilink Midlands and Cytecom\, will convene experts and stakeholders from across the antimicrobial resistance landscape to share insights\, showcase innovations\, and foster collaboration. Covering the spectrum from cutting-edge academic research to real-world implementation\, policy\, and surveillance\, this year’s programme offers essential discussions for anyone working in AMR or related fields. \nThis year\, we will also explore the far-reaching impact of AMR beyond the specialist sphere—shaping policy\, influencing cancer care pathways\, and protecting other vulnerable patient groups.\n\n\n  \nReasons to Attend\n1. Be at the forefront of AMR innovation: Connect with leading innovators\, researchers\, and industry experts driving advancements in combating antimicrobial resistance. Discover the latest breakthroughs and explore potential collaborations. \n2. Support SMEs and foster growth: Learn about innovative solutions developed by small and medium enterprises (SMEs) and contribute to their success. Network with like-minded individuals to create new partnerships and drive innovation. \n3. Gain valuable insights and knowledge: Attend engaging presentations and discussions on the latest trends and challenges in the field of AMR. Expand your understanding of the issue and stay ahead of the curve. \n4. Network with key stakeholders: Connect with representatives from organisations like Medilink Midlands\, WMHTIA\, Cytecom\, University of Warwick and Microbiology Society. Build relationships and explore potential partnerships. \n5. Contribute to a global cause: Join the fight against antimicrobial resistance by attending this event. Be part of a community dedicated to raising awareness\, promoting best practices\, and driving positive change. \n  \n \n  \nAgenda\n9:30am                                Arrival & registration  \n10am                                    Introduction followed by Opening Remarks from Dame Sally Davies \n10:15am                              Session 1: Institute to Impact – Research to Commercialisation  \n– Chris Dowson – Warwick AMR Facilities \n– Kim Hardie – National Biofilms Innovation Centre \n  \n11am                                  Comfort break\, poster boards & networking  \n11:30am                            Session 2: Diagnostics Panel Discussion \nPanelists: \n\nPhil Packer -Innovate UK\nBob Roopra – Roopra Medical\nLucy Lehane – BIVDA and Lehane Consulting\nWilliam Finch – Oxford Vacmedix\n\n  \n12:30pm                            Lunch  \n1:30pm                              Session 3: Policy Workshop – Delivered by Microbiology Society  \n                                           (Will Thompson\, Policy and Engagement Officer) \nThe Microbiology Society is leading the way in tackling AMR through its ambitious and wide-reaching Knocking Out AMR project. This initiative  promotes innovative solutions to AMR by fostering cross-sector collaboration and driving policy action. The session will open with a presentation introducing AMR policy and regulation tailored for SMEs\, followed by a panel discussion featuring experts working across therapeutics\, diagnostics\, vaccines and regulation. \n  \n2:30pm                              Session 4: AMR and Cancer/Environmental  \n– David Eyre – Oxford Biomedical Research Centre \n  \n3:30pm                               Networking and posters to end  \n4:30pm                               Depart  \n\n\n\nIf anyone would like to register their interest in presenting a poster\, please click the link: Innovations Against AMR – Friday 21st November 2025\n*Please register your interest by 5pm on 27th October. \n\n  \nSpeaker Information\nProfessor Kim Hardie FRSB \nProfessor Kim Hardie FRSB\, Professor in Bacterial Pathogenesis is Co-director of the National Biofilms Innovation Centre (NBIC) at the University of Nottingham and Chair of the Publishing Panel at the Microbiology Society. Kim’s international career investigating strategies that could circumvent the rising issue of antimicrobial resistance (AMR) includes study at the Universities of Leicester and Cambridge. Kim’s research group investigates how bacteria form coordinated communities (biofilms) since these are notoriously hard to treat and have life-changing consequences. State-of-the-art multidisciplinary approaches are combined with realistic polymicrobial infection models to discover novel antimicrobials\, more effective combination therapies\, or diagnostic biomarkers. \n  \n  Professor Chris Dowson \nProfessor Chris Dowson has\, for many years\, examined the emergence and evolution of antibiotic resistance across a wide range of bacteria. His recent focus has been to better understand how penicillin targets bacteria. He currently holds a personal chair at Warwick University and is a past member of the Medical Research Council Infections and Immunity Board. He has established the Sir Howard Dalton Centre HDC for Translational Mechanistic Enzymology and is co-director of this and the Warwick Antimicrobial Interdisciplinary Centre WAMIC. He enabled the location of the Medicines Discovery Catapult MDC AMR Laboratory facility at Warwick and has been involved with philanthropic research fundraising regionally across Warwickshire for the past 20 years. \n  \n \nBob Roopra MBA FCIM  \nBob has over 25 years of experience in the IVD and medical devices industry\, with a wealth of expertise in executive leadership\, start-ups\, scale-ups\, commercialisation\, consulting\, advisory\, strategic planning\, and implementation. His specialisations encompass IVD diagnostics\, medical devices\, point-of-care solutions\, informatics\, and disruptive technologies. \nBob’s broad experience across diverse sizes of organisation sizes has provided him with deep insights into strategic direction setting and commercial planning. His comprehensive knowledge of the IVD and medical device sectors\, combined with his skill in crafting and executing business strategies\, ensures outcomes that balance clinical\, financial\, and operational priorities for sustained commercial enterprise success. \n  \n  Phil Packer \nPhil Packer is the Innovation Lead on AMR and Vaccines at Innovate UK\, developing & delivering funding calls\, supporting workshops and strategy. This includes overseeing projects funded through IUK funding mechanisms such as the Biomedical Catalyst and SMART programme\, and the IUK AMR Global Programme. \nPhil is the IUK Responsible Officer for AMR initiative PACE (Pathways to Antimicrobial Clinical Efficacy)\, a co-creation with LifeArc and the Medicines Discovery Catapult\, a UK\, £30M\, nationally coordinated programme that supports both academic and SME translation\, integrated with the UK science base and the international community to contribute innovative and precision therapeutics and associated diagnostics to the global infectious disease pipeline in areas of unmet patient need (especially under-served communities).\nPhil is also the IUK lead for the delivery of a £40M DHSC\, UK Vaccine Network programme delivering vaccine with outbreak potential in Low- and Middle-Income Countries. \n  \n William Finch \n\nBiochemistry\, University of Oxford\n>34 years experience in biotech sector with a focus on leading SMEs\nWide experience with  Dx industry\nAmersham\, DSL\, Beckman Coulter\nCEO\, R&D Systems Europe\nCEO \,Oxford Bio-Innovation\nScientific Committee\, UK ACB\n\n  Lucy Lehane \nLucy is an independent Medical Diagnostics Consultant who began her career in the National Health Service as a Clinical Scientist. It was here that she gained first hand insights into the importance of diagnostic testing in improving health and disease management\, and enhancing patient experiences. Fast forward nearly 25 years\, and Lucy has spent her career in the commercial world of diagnostic testing holding leadership roles in Product Management\, Technical Marketing and Medical Affairs for several leading diagnostic companies.\nIn 2023\, Lucy established her own consultancy business – Lehane Consulting Ltd. providing medical diagnostics expertise to guide businesses to bring their diagnostic products to market. Lucy endeavours to apply her 25 years of experience in the IVD industry to provide expert advice for product development\, market understanding\, devising clinical studies and communications to help bring products to life. \n \nWill Thompson  \nWill studied Biotechnology at the University of Nottingham\, followed by a Master’s in Science and Technology Policy at the University of Sussex. As Policy and Engagement Officer at the Microbiology Society\, Will has played a key role in shaping the Society’s policy outputs and stakeholder engagement around AMR. This includes a policy briefing on AMR in wastewater and developing AMR international engagement activities with the UK’s Science and Technology Network (STN). \n  \n  \n \nProfessor David Eyre \nDavid Eyre is a Professor of Infectious Diseases at the University of Oxford and a Consultant in Infection at Oxford University Hospitals. His research uses routinely collected data to understand who gets different infections and why\, and how best to prevent\, treat and monitor these infections. He also focuses on developing artificial intelligence tools to help diagnose and treat hospital patients\, and to help operational delivery of healthcare. His other research interests include the use of whole-genome sequencing as a tool for understanding the epidemiology and transmission of pathogens and how it can best be used in infection prevention and control. \n  \n  \n  \nTo read more about Medilink Midlands’ role within the WMHTIA project\, click here. \nFor more information on the wider project\, click here to visit the WMHTIA website. \nThis event forms part of the West Midlands Health Tech Innovation Accelerator (WMHTIA) event series. Medilink Midlands are one of a consortium of delivery partners for the WMHTIA\, a project funded by the Department for Science\, Innovation and Technology\, Innovate UK and West Midlands Combined Authority (part of City Regions).
URL:https://staging.medilinkmidlands.com/event/in-person-event-design-for-health-med-tech-innovation-2-2/
LOCATION:Scarman Conference Facility at Warwick Conferences\, University of Warwick\, Coventry\, CV4 7SH\, United Kingdom
CATEGORIES:Medilink Midlands Event
ORGANIZER;CN="Linsey Horsepool Medilink Midlands":MAILTO:events@medilinkmidlands.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20251125T100000
DTEND;TZID=Europe/London:20251125T110000
DTSTAMP:20260407T163742
CREATED:20251110T095859Z
LAST-MODIFIED:20251110T100318Z
UID:39282-1764064800-1764068400@staging.medilinkmidlands.com
SUMMARY:Online - Monthly Membership Drop-In session
DESCRIPTION:Launched in May\, the new Member Portal provides members with access to wider community reach\, knowledge sharing\, exclusive member offers\, forum discussions and access to event & training materials – all in one place. \nMember Forum – no registration required\, just sign into the portal\, head the Member Forum and join the conversation! \nIf you are a member and not yet signed up to the portal\, click here to unlock your access. \nNon members are invited to explore open areas of the portal – to receive full access join our membership starting from £275+VAT. \nOur Monthly Membership Drop-In Session is an open space for members to ask questions\, share feedback\, and engage with the Medilink Midlands team. These informal drop-in sessions take place on the last Tuesday of each month. \nEach session focuses on a specific topic. The next forum will be held on: \nTuesday\, 25th NovemberTopic: Feedback from the Winter Networking & 2025 Medilink Midlands Highlights\, plus a discussion on the upcoming events: \n\n27.11.2025: Going Digital – Empowering Innovators to Engage with the NHS of Tomorrow (In-Person)\n09.12.2025: WMHTIA Cluster: Community: Driving Local Innovation to Meet Regional NHS Challenges (Webinar)\n13.01.2026: WMHTIA Cluster: Prevention – Innovating for a Healthier Future (Webinar)\n\nWe look forward to seeing you there!
URL:https://staging.medilinkmidlands.com/event/monthly-drop-in-session-november/
LOCATION:Online – Members Portal
CATEGORIES:Medilink Midlands Event
ORGANIZER;CN="Reena Mistry":MAILTO:reena@medilinkmidlands.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20251127T100000
DTEND;TZID=Europe/London:20251127T130000
DTSTAMP:20260407T163742
CREATED:20250821T123801Z
LAST-MODIFIED:20251110T163519Z
UID:37815-1764237600-1764248400@staging.medilinkmidlands.com
SUMMARY:IN-PERSON EVENT: Going Digital - Empowering Innovators to Engage with the NHS of Tomorrow
DESCRIPTION:                        \nHelping innovators navigate digital transformation in light of the NHS 10-Year Plan. \nInsight 1: Building Digital Health Tools for the NHS \nMedilink Midlands are delighted to be collaborating with Arise Innovation Hubs and Innovate UK in a series of events for autumn and winter 2025/26.  The first of these looks at one the common themes in the NHS’s current 10-year plan\, which aims to make the NHS fit for the future.\nWe will explore how to design and deploy effective\, scalable digital apps tailored for NHS use — from prototype to practical implementation. Hearing from those who have successfully delivered into the NHS\, those currently developing innovations and those who can support the innovator. \nHow do we create the reality of ‘a doctor in our pocket’ \nAgenda: \n10.00am      Registration & networking \n10.30am      Introduction and Welcome by Arise & Medilink Midlands teams \nEvent Chair: Dr Beverley Vaughan \n10.45am      Setting the challenge and how innovators step up – Dr Michael Watts MBA MBChB BSc (Hons) Young Health Tech Leader of the Year 2024\, Health Tech World\, Co-Founder and CEO\, Blüm Health Ltd\, NHS Innovation Accelerator Fellow\, NHS England Clinical Entrepreneur & Mentor\n \n11.15am       Lightening pitches \n\nMatt Lavis\, Head of Technology – SkyRocket Phytopharma\nMuntazir Panjwani\, Director – Vibe Agency\nUzma Sajjad\, Founder – RescQ\nJamie Tidman\, CEO – ND Lens\n\n11.30am      Q&A \n11.45am      Support available to innovators \n\nRegulatory: John Connah – EG Technologies\nR&D Tax: Peter Clark and Younes Fegheh-Hassanpour – RCKPartners\nInnovate UK: Mike Herd\, Ecosystem Innovation Growth Specialist\nHealth Innovation East: Lamprini Kaftantzi\, PHD – Senior Advisor (Commercial)\n\n12.00pm     Networking lunch \n1:00pm       Depart \n  \n\n  \nSpeakers: \nEvent Chair: Dr Beverley Vaughan\, Arise Innovation Hubs Director \nBeverley is a scientist by training\, having worked in academia\, start-up and business sectors\, including Cambridge University Teaching hospitals\, Stevenage Bioscience Catalyst (SBC)\, Cell and Gene Therapy Catapult and University of Oxford. Currently\, Director at Arise Innovation hubs\, part of Anglia Ruskin University\, small but beautifully formed and importantly close but not within the golden triangle powerhouses. Beverley has been building a pipeline and success stories in the local environment has involved using knowledge of other clusters and adaptation to a different ecosystem.  Collaborating with our community to harness the skills and talent in ARU to support them\, on a bespoke and case by case basis. Proud to have delivered programmes such as ABOVE and learnt how being small can make you nimble but success relies on powerful and strategic partnership. \n  \n  \n Dr Michael Watts MBA MBChB BSc (Hons)\, Co-Founder and CEO at Blüm Health \nMichael is the Young Health Tech Leader of the Year 2024\, an NHS doctor\, NHS Innovation Accelerator Fellow and MBA Graduate by background. Over the last few years\, he has been the CEO of Blüm Health\, an award-winning digital health organisation that collaboratively works with Hospitals\, SMEs and Large Corporates to design\, build\, and scale digital health software solutions\, in the hope to empower public and private sector organisations to boost their digital maturity and unlock their innovative potential. Michael has extensive experience in supporting NHS organisations design\, build and procure digital health ecosystems and understands the importance of digital inclusivity from a patient\, workforce and organisational perspective. \n  \n \nMatt Lavis\, Chief Technology Officer at Skyrocket Phytopharma \nMatt is the Chief Technology Officer for Skyrocket Phytopharma\, the distributor and Responsible Person for the Neuropad\, Sudopad and Sudometrics products in the United Kingdom. Matt collaborates with clinical experts to lead the development and integration of innovative technologies that improve patient care and safety\, overseeing product design\, engineering\, and regulatory compliance. \nMatt has spent 25 years leading digital projects in both the private and public sector for diverse organisations such as HMRC\, Department for Business and Trade\, Sainsbury’s and Argos\, with a recent history of delivering a number of key post-Brexit UK trade platforms. \n  \n \n  \nMuntazir Panjwani\, Co-Founder at Vibe Agency \nMuntazir Panjwani is a co-founder of Vibe Agency\, a tech consultancy that builds digital platforms across healthcare\, education and the public sector. He leads product direction and delivery\, building scalable solutions used by clinicians\, staff\, learners and administrators. With over a decade of experience\, Vibe Agency has delivered learning and workforce platforms and operational tools for NHS organisations\, Integrated Care Boards (ICBs)\, Local Medical Committees and Training Hubs. Muntazir also mentors on the NHS Clinical Entrepreneurs Programme\, supporting innovators to build new digital solutions in healthcare.         \n  \n   Dr Uzma Sajjad\, Founder at RescQ \nUzma is an interventional cardiology trainee and somewhere between coronary wires and stents\, found an interest in improving outcomes for out-of-hospital cardiac arrests. The operational lead for RescQ – a digital solution to support to the forgotten bystanders\, who step in during the life or death moments of a cardiac arrest\, before help arrives. \n                      \n  \n                 \n  Jamie Tidman\, CEO at ND Lens \nJamie is an experienced CTO with a 13-year background in software development – 8 of which have included building language AI products in use within the NHS and other healthcare organisations. As CEO of ND Lens\, Jamie is leading the development of a platform which uses AI to transform ADHD and autism assessments\, cutting wait times and clinician workload. The accessible platform streamlines diagnosis\, supports patients during delays\, and helps health services tackle growing backlogs efficiently. \n  \n   John Connah\, Software Team Lead at eg technology \nJohn has over 30 years of experience in coordinating cross-disciplinary teams delivering complex software projects to regulatory standards across multiple platforms and development environments. As an experienced software engineer\, he offers guidance\, mentorship and technical direction on complex projects across the product development roadmap. John leads the software group at eg technology and has worked across a broad section of industry including MedTech\, BioTech\, AgriTech and Consumer sectors. He has extensive experience in medical software\, video and image processing and scientific and biomedical instrumentation control. \n  \n  \nPeter Clark PhD\, Co-founder and R&D Technical Director at RCK Partners \nAs an experienced R&D professional\, Peter completed an engineering doctorate whilst working within a FTSE 100 central R&D department and subsequently worked in development engineering\, refining precious metals\, before undertaking management consulting work to implement innovation software. Having worked within one of Europe’s largest innovation funding providers\, Peter has worked extensively on engineering\, construction\, manufacturing\, and agricultural R&D claims. With a core background in R&D and Chemical Engineering\, Peter can better understand the challenges encountered by his clients\, applying technology driven solutions into corporation tax services on behalf of clients.    \n  \n \nYounes Fegheh-Hassanpour PhD\, R&D Manager at RCK Partners \nYounes is Head of Life-Sciences and an R&D Tax Manager at RCK\, with a D.Phil in Organic Chemistry from the University of Oxford and a Master’s in Pharmaceutical Chemistry from Queen Mary University. With over six years of experience as an R&D tax specialist\, Younes also brings a strong background in industrial drug development. His expertise spans complex drug design\, custom synthesis\, and process development for regulatory-controlled substances used in Phase I and II clinical trials. He has extensive experience in GMP and GLP environments\, including large-scale reactor development\, early-stage steroid pharmaceutical formulation\, and the synthesis of carbohydrates for targeted disease control. Younes has been closely involved in multiple stages of the drug development lifecycle\, from strategy and implementation to hands-on execution of long-term R&D programmes. \n  \n  Mike Herd\, Ecosystem Innovation Growth Specialist \nAn experienced business advisor\, Mike has worked with many hundreds of tech entrepreneurs supporting them to realise the potential of their businesses and themselves. \nAs part of his Innovate UK role\, Mike works with stakeholders across Cambridge to develop the investor ecosystem and to identify and support new high-growth potential tech businesses. \n  \n\nDr Lamprini Kaftantzi\, Senior Advisor at Health Innovation East \nDr Lamprini leads international projects that support overseas companies in navigating the NHS\, as well as helping UK companies achieve success in international markets. Additionally\, she is the Oncology Lead\, helping innovators and SMEs bring oncology innovations into the NHS and supporting providers with the implementation and evaluation of new solutions. Lamprini trained in biology and genetics before completing her doctoral studies on the clinical and commercial translation of advanced cell therapies. She previously worked as a market access consultant\, and a Health Technology Assessor of medical devices and diagnostics for one of NICE’s External Assessment Centres. \n  \n  \nCurrent positions: \n\nInnovate UK – Cambridge Ecosystem\nSenior Innovation & Growth Specialist / Investment\nVisiting Professor – Anglia Ruskin University.\nChair of ARU’s Enterprise & Entrepreneurship External Advisory Panel.\nBoard advisor for technology businesses.\nHolder of the Queens Award for Enterprise.\n\nMike ran the Sussex Innovation Centre\, a leading UK technology business incubator for over twenty years. He acted as a guide and advisor for businesses at all stages from start-up to flotation. He built a high-performing team of advisors and business support staff – including a successful intern scheme. He developed and delivered award-winning entrepreneurial support programmes. \nIn addition\, Mike led on new research commercialisation and student start-up initiatives at the University of Sussex. \nAlso\, an author of novels based on the experiences of start-up entrepreneurs
URL:https://staging.medilinkmidlands.com/event/in-person-event-east-of-england-healthtech-cluster-connecting-people-creating-opportunity-2-2/
LOCATION:Arise Chelmsford Innovation Hub\, Alan Cherry Drive\, Chelmsford\, Essex\, CM1 1QT\, United Kingdom
CATEGORIES:Medilink Midlands Event
ORGANIZER;CN="Linsey Horsepool Medilink Midlands":MAILTO:events@medilinkmidlands.com
END:VEVENT
END:VCALENDAR